Clinical Trials Sponsored by Seneque SA

Total 1043 results

Medacta International SA

Active, not recruiting

The Medacta International GMK Sphere Post-Marketing Surveillance Study

Arthritis | Rheumatoid Arthritis | Avascular Necrosis | Traumatic Arthritis | Poly-arthritis

Belgium, United Kingdom
Medacta International SA

Active, not recruiting

AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study

Arthritis | Osteoarthritis | Avascular Necrosis | Congenital Hip Dysplasia | Fracture of the Femoral Neck or Head

Switzerland, United Kingdom
Medesis Pharma SA

Terminated

NanoMn®_COVID-19 A Prospective, Multicenter, Randomized, Placebo-controlled, Parallel-group, Double-blind Trial to Evaluate the Clinical Efficacy of NanoManganese® on Top of Standard of Care, in Adult Patients With Moderate to Severe Coronavirus Disease 2019 (COVID-19)

COVID-19 Pandemic

Brazil
Medacta International SA

Suspended

Mpact Cup Performance After Total Hip Arthroplasty

Total Hip Replacement

France
Rheon Medical SA

Active, not recruiting

eyeTube in Combination With the eyeWatch Implant

Aqueous Humor Drainage

Senegal
OM Pharma SA

Terminated

Immunomodulation by OM-85 (Broncho-Vaxom) in Early AD

Atopic Dermatitis

Germany, France, Poland, Netherlands
Contrad Swiss SA

Completed

Investigation on a Topical Cosmetic Pain Lotion (Egyfil) for Stiffness and Pain Relief

Pain | Muscle Rigidity

Italy
Rhizen Pharmaceuticals SA

Completed

Compassionate Use Study of Tenalisib (RP6530)

Hematological Malignancies

United States, Georgia, Poland
Medacta International SA

Completed

Cortical Bone Trajectory With Patient Guide (MySpine MC)

Degenerative Disc Disease

Belgium
Vexim SA
Statitec

Completed

SpineJack® Versus Conservative Treatment Study (SPICO Study)

Trauma | Spinal Fractures | Back Injuries | Vertebral Compression Fractures

France
Helsinn Healthcare SA

Completed

A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer | Cachexia; Cancer

United States, Russian Federation, Bulgaria, Hungary, Italy, Romania, Serbia
Helsinn Healthcare SA

Completed

A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer | Cachexia; Cancer

United States, Croatia, Australia, Belgium, Russian Federation, Poland, Romania, Ukraine
Contrad Swiss SA

Completed

Evaluation of the "ST500 SINGLE- DOSE GEL" in Patients With Symptomatic Long Head of the Biceps Tendon Injury

Long Head of Biceps Rupture

Italy
Medacta International SA

Terminated

A Multi-centre, Prospective Surveillance to Assess Mid-term Performance of the Mpact Cup

Arthritis | Osteoarthritis | Avascular Necrosis | Congenital Hip Dysplasia | Fracture of the Femoral Neck or Head

United States
Medacta International SA

Terminated

MOTO Post-marketing Surveillance Study

Osteo Arthritis Knee | Osteonecrosis

Belgium
Medacta International SA

Active, not recruiting

AMIStem-H Radiological Assessment

Hip Replacement Arthroplasty

France
AB Biotics, SA

Terminated

Effect of a Probiotic Formula on Reducing SIBO in IBS Patients

Irritable Bowel Syndrome | Small Intestinal Bacterial Overgrowth

Spain
Rhizen Pharmaceuticals SA

Completed

Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma

T Cell Lymphoma

United States
Sword Health, SA

Enrolling by invitation

Digital Care Programs for Female Pelvic Health

Pelvic Organ Prolapse | Pelvic Pain | Pelvic Floor Disorders | Pelvic Floor Muscle Weakness | Pelvic Pain Syndrome

United States
Sword Health, SA

Enrolling by invitation

Digital Care Programs for Musculoskeletal Health

Musculoskeletal Diseases

United States
AB Biotics, SA

Completed

Effect of a Multi-strain Probiotic Formulation on Immune Response to Influenza Vaccination (FLUVAC21)

Influenza Vaccine

Spain
Helsinn Healthcare SA

Terminated

A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes

Myelodysplastic Syndromes

United States
Rheon Medical SA

Completed

Clinical Investigation of the eyeWatch Glaucoma Drainage Device

Open Angle Glaucoma

United Kingdom
Rhizen Pharmaceuticals SA

Completed

A Single and Multiple Ascending and Food Effect Study of RP7214, a DHODH Inhibitor in Healthy Adult Subjects

Healthy Volunteers

United States
AB Biotics, SA

Completed

Observational Prospective Study With Probiotic Supplementation on Infants With FGDI

Functional Gastrointestinal Disorders | Infantile Colic | Functional Constipation

Italy
Bio Sidus SA

Unknown

Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney Disease

Anemia of Chronic Kidney Disease

Argentina, Paraguay
Regen Lab SA

Unknown

Comparative Evaluation of A-CP HA Kit, Hyaluronic Acid and Placebo for the Treatment of Knee Osteoarthritis

Knee Osteoarthritis

United States
Helsinn Healthcare SA

Completed

Monocenter, Open Label Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Xonrid®

Quality of Life | Radiodermatitis

Italy
Labatec Pharma SA

Unknown

Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes

Osteoporosis, Postmenopausal

Switzerland
AB Biotics, SA

Terminated

Combined Nutritional Therapies for the Treatment of Ulcerative Colitis

Colitis, Ulcerative

Spain
Celyad Oncology SA

Unknown

Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases (SHRINK)

Colon Cancer Liver Metastasis

Belgium
Rhizen Pharmaceuticals SA

Completed

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral

United States
Regen Lab SA

Completed

Autologous Platelet Concentrate Combined to Hyaluronic Acid Obtained With Cellular Matrix® BCT-HA Kit and Vulvovaginal Dryness

Vulvar Atrophy

France
Regen Lab SA

Unknown

Evaluation of the Benefit of the Use of Autologous Glue Prepared With RegenKit®-Surgery Device in Abdominoplasty

Abdominoplasty
MedDay Pharmaceuticals SA

Completed

Effect of MD1003 in Amyotrophic Lateral Sclerosis (MD1003-ALS)

Motor Neuron Disease | Amyotrophic Lateral Sclerosis | ALS

France
Pixium Vision SA

Completed

Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy (IRIS 2)

Retinitis Pigmentosa | Choroideremia | Cone Rod Dystrophy

Austria, Spain, United Kingdom, France, Germany
Biosensors Europe SA

Completed

Limus Eluted From A Durable Versus ERodable Stent Coating (LEADERS)

Coronary Disease | Coronary Stenosis

Belgium, France, Germany, Netherlands, Poland, Switzerland, United Kingdom
Cerenis Therapeutics, SA

Terminated

CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases (TANGO)

Familial Hypoalphalipoproteinemia

France, United States, Belgium, Canada, Israel, Italy, Netherlands
Debiopharm International SA

Completed

Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas

Lymphoma | Cancer | Solid Tumors | Malignancy

United States
Quantum Genomics SA

Completed

Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins (NEW-HOPE)

Hypertension

United States
Helsinn Healthcare SA

Completed

Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome

Myelodysplastic Syndrome

United States
Celyad Oncology SA

Completed

Safety and Efficacy of Autologous Cardiopoietic Cells for Treatment of Ischemic Heart Failure. (CHART-1)

Heart Failure

Spain, Israel, Belgium, Switzerland, Italy, Bulgaria, Hungary, Poland, Serbia
Debiopharm International SA

Completed

A Study to Investigate the Effect of Itraconazole on the Pharmacokinetics of Debio 1450 in Healthy Subjects

Healthy Participants

United Kingdom
Pixium Vision SA

Completed

Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy (IRIS-1)

Retinitis Pigmentosa | Choroideremia | Cone Rod Dystrophy

Austria, France, Germany
Aleva Neurotherapeutics SA

Completed

Evaluation of Directional Stimulation During the Implantation of Deep Brain Stimulation (DBS) Leads

Parkinson's Disease | Essential Tremor

Switzerland
Medacta International SA

Completed

Periprosthetic Bone Mineral Density After Total Hip Arthroplasty Performed Through a Minimally Invasive Anterior Approach (AMIS) With Either an AMIStem or a Quadra Femoral Component

Arthritis | Osteoarthritis | Avascular Necrosis | Congenital Hip Dysplasia | Fracture of the Femoral Neck or Head

Germany
Debiopharm International SA

Completed

Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option

Hepatitis C | Liver Disease

United States, France
Regen Lab SA

Completed

Autologous Platelet Rich Plasma Combined to Hyaluronic Acid Obtained With Regen-Kit BCT-HA in Aesthetic Medicine

Skin Wrinkling
Debiopharm International SA

Completed

Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment

Hepatitis C

Romania, Italy, Hungary, Taiwan, Turkey, Belgium, Spain, Germany, Australia, France, United States, United Kingdom, Poland, Puerto Rico
Debiopharm International SA

Terminated

Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C

Hepatitis C

United States, Germany, France, Spain, Italy, United Kingdom, Puerto Rico, Canada

Clinical Trials Sponsored by Seneque SA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations